Melatonin affects voltage-dependent calcium and potassium currents in MCF-7 cell line cultured either in growth or differentiation medium.

Big efforts have been dedicated up to now to identify novel targets for cancer treatment. The peculiar biophysical profile and the atypical ionic channels activity shown by diverse types of human cancers suggest that ion channels may be possible targets in cancer therapy. Earlier studies have shown that melatonin exerts an oncostatic action on different tumors. In particular, it was shown that melatonin was able to inhibit growth/viability and proliferation, to reduce the invasiveness and metastatic properties of human estrogen-sensitive breast adenocarcinoma MCF-7 cell line cultured in growth medium, with substantial impairments of epidermal growth factor (EGF) and Notch-1-mediated signaling. The purpose of this work was to evaluate on MCF-7 cells the possible effects of melatonin on the biophysical features known to have a role in proliferation and differentiation, by using the patch-clamp technique. Our results show that in cells cultured in growth as well as in differentiation medium melatonin caused a hyperpolarization of resting membrane potential paralleled by significant changes of the inward Ca(2+) currents (T- and L-type), outward delayed rectifier K(+) currents and cell capacitance. All these effects are involved in MCF-7 growth and differentiation. These findings strongly suggest that melatonin, acting as a modulator of different voltage-dependent ion channels, might be considered a new promising tool for specifically disrupting cell viability and differentiation pathways in tumour cells with possible beneficial effects on cancer therapy.

[1]  G. Rozenberg,et al.  The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. , 2002, Molecular pharmacology.

[2]  F. Sbrana,et al.  Role for stress fiber contraction in surface tension development and stretch-activated channel regulation in C2C12 myoblasts. , 2008, American journal of physiology. Cell physiology.

[3]  S. Hill,et al.  Melatonin and Associated Signaling Pathways that Control Normal Breast Epithelium and Breast Cancer , 2011, Journal of Mammary Gland Biology and Neoplasia.

[4]  L. Pardo Voltage-gated potassium channels in cell proliferation. , 2004, Physiology.

[5]  G. Farrugia,et al.  Effects of melatonin on ionic currents in cultured ocular tissues. , 1999, American journal of physiology. Cell physiology.

[6]  D. Currò K+ channels as potential targets for the treatment of gastrointestinal motor disorders. , 2014, European journal of pharmacology.

[7]  M. Melan,et al.  Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives , 2009, Expert Reviews in Molecular Medicine.

[8]  S. Cos,et al.  Melatonin and Mammary Pathological Growth , 2000, Frontiers in Neuroendocrinology.

[9]  D. Cardinali,et al.  Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms , 2008, Integrative cancer therapies.

[10]  K. Kunzelmann Ion Channels and Cancer , 2005, The Journal of Membrane Biology.

[11]  Bartosz Pula,et al.  Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma , 2013, Journal of pineal research.

[12]  E. Carbone,et al.  Exposure to cAMP and β‐adrenergic stimulation recruits CaV3 T‐type channels in rat chromaffin cells through Epac cAMP‐receptor proteins , 2004, The Journal of physiology.

[13]  J. Striessnig,et al.  Loss of Cav1.3 Channels Reveals the Critical Role of L-Type and BK Channel Coupling in Pacemaking Mouse Adrenal Chromaffin Cells , 2010, The Journal of Neuroscience.

[14]  E. Werstiuk,et al.  Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation. , 2007, European journal of pharmacology.

[15]  Tripp Frasch,et al.  Molecular Mechanisms of Melatonin Anticancer Effects , 2009, Integrative cancer therapies.

[16]  A. Arcangeli,et al.  American Journal of Physiology-Cell Physiology theme: ion channels and transporters in cancer. , 2011, American journal of physiology. Cell physiology.

[17]  So Yeong Lee,et al.  Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells. , 2005, The international journal of biochemistry & cell biology.

[18]  R. Girgert,et al.  Membrane‐bound melatonin receptor MT1 down‐regulates estrogen responsive genes in breast cancer cells , 2009, Journal of pineal research.

[19]  N. Ahmad,et al.  Melatonin in cancer management: progress and promise. , 2006, Cancer research.

[20]  L. Formigli,et al.  Combined effects of melatonin and all-trans retinoic acid and somatostatin on breast cancer cell proliferation and death: molecular basis for the anticancer effect of these molecules. , 2012, European journal of pharmacology.

[21]  C. Alonso-González,et al.  Breast cancer therapy based on melatonin. , 2012, Recent patents on endocrine, metabolic & immune drug discovery.

[22]  M. Nazıroğlu,et al.  Role of melatonin on electromagnetic radiation-induced oxidative stress and Ca2+ signaling molecular pathways in breast cancer , 2012, Journal of receptor and signal transduction research.

[23]  J. Yamazaki,et al.  T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells. , 2012, International journal of oncology.

[24]  Andrea Becchetti,et al.  Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer. , 2011, American journal of physiology. Cell physiology.

[25]  BKCa-Cav Channel Complexes Mediate Rapid and Localized Ca2+-Activated K+ Signaling , 2006, Science.

[26]  W. Wonderlin,et al.  An ATP-Sensitive K+ Current that Regulates Progression Through Early G1 Phase of the Cell Cycle in MCF-7 Human Breast Cancer Cells , 1999, The Journal of Membrane Biology.

[27]  F. Wrba,et al.  The mRNA of L-type calcium channel elevated in colon cancer: protein distribution in normal and cancerous colon. , 2000, The American journal of pathology.

[28]  E. Aydar,et al.  Abnormal expression, localization and interaction of canonical transient receptor potential ion channels in human breast cancer cell lines and tissues: a potential target for breast cancer diagnosis and therapy , 2009, Cancer Cell International.

[29]  S. Hill,et al.  Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin , 2011, Breast Cancer Research and Treatment.

[30]  G. Brooks,et al.  The role of voltage gated T-type Ca2+ channel isoforms in mediating "capacitative" Ca2+ entry in cancer cells. , 2004, Cell calcium.

[31]  H. Sowter,et al.  Eag and HERG potassium channels as novel therapeutic targets in cancer , 2010, World journal of surgical oncology.

[32]  H. Sevestre,et al.  Intermediate conductance Ca2+ activated K+ channels are expressed and functional in breast adenocarcinomas: correlation with tumour grade and metastasis status. , 2010, Histology and histopathology.

[33]  G. Perigli,et al.  Characterization of human adult stem‐cell populations isolated from visceral and subcutaneous adipose tissue , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  E. Condom,et al.  Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer. , 2009 .

[35]  Mansoor Abdul,et al.  Activity of potassium channel-blockers in breast cancer. , 2003, Anticancer research.

[36]  F. Lang,et al.  Regulation of Channels by the Serum and Glucocorticoid-Inducible Kinase - Implications for Transport, Excitability and Cell Proliferation , 2003, Cellular Physiology and Biochemistry.

[37]  Gabriella Nesi,et al.  Functional Differences in Visceral and Subcutaneous Fat Pads Originate from Differences in the Adipose Stem Cell , 2012, PloS one.

[38]  C. Lingle,et al.  BK channel activation by brief depolarizations requires Ca2+ influx through L- and Q-type Ca2+ channels in rat chromaffin cells. , 1999, Journal of neurophysiology.

[39]  David L. Kaplan,et al.  Role of Membrane Potential in the Regulation of Cell Proliferation and Differentiation , 2009, Stem Cell Reviews and Reports.

[40]  Vijayalaxmi,et al.  Melatonin: from basic research to cancer treatment clinics. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  O. Crociani,et al.  Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. , 2009, Current medicinal chemistry.

[42]  P. Cohen,et al.  IGF-1 up-regulates K+ channels via PI3-kinase, PDK1 and SGK1 , 2002, Pflügers Archiv - European Journal of Physiology.

[43]  Zhiguo Wang Roles of K+ channels in regulating tumour cell proliferation and apoptosis , 2004, Pflügers Archiv.

[44]  H. Ouadid‐Ahidouch,et al.  K+ Channel Expression in Human Breast Cancer Cells: Involvement in Cell Cycle Regulation and Carcinogenesis , 2007, Journal of Membrane Biology.

[45]  Michael Levin,et al.  Bioelectric controls of cell proliferation: Ion channels, membrane voltage and the cell cycle , 2009, Cell cycle.

[46]  J. Massagué TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[47]  A. Zuccotti,et al.  Equal sensitivity of Cav1.2 and Cav1.3 channels to the opposing modulations of PKA and PKG in mouse chromaffin cells , 2012, The Journal of physiology.

[48]  L. Formigli,et al.  Cytoskeleton/stretch‐activated ion channel interaction regulates myogenic differentiation of skeletal myoblasts , 2007, Journal of cellular physiology.

[49]  T. Maéno,et al.  Involvement of the Ca2+‐dependent K+ channel activity in the hyperpolarizing response induced by epidermal growth factor in mammary epithelial cells , 1986, FEBS letters.

[50]  M. Vassalli,et al.  Sphingosine 1-phosphate induces Ca2+ transients and cytoskeletal rearrangement in C2C12 myoblastic cells. , 2002, American journal of physiology. Cell physiology.